DNA aptamer evolved by cell-SELEX for recognition of prostate cancer.
Morbidity and mortality of prostate cancer (PCa) have increased in recent years worldwide. Currently existing methods for diagnosis and treatment do not make the situation improve, especially for hormone refractory prostate cancer (HRPC). The lack of molecular probes for PCa hindered the early diagn...
Guardado en:
Autores principales: | Yuanyuan Wang, Yun Luo, Tao Bing, Zheng Chen, Minhua Lu, Nan Zhang, Dihua Shangguan, Xin Gao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cb362c008bf4e1ba3174b1ec5983af0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
por: Chen L, et al.
Publicado: (2018) -
Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX
por: Guodong Wang, et al.
Publicado: (2017) -
Selection of aptamers for mature white adipocytes by cell SELEX using flow cytometry.
por: Eun Young Kim, et al.
Publicado: (2014) -
Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
por: Kaylin G. Earnest, et al.
Publicado: (2021) -
Probing the SELEX process with next-generation sequencing.
por: Tatjana Schütze, et al.
Publicado: (2011)